GLP-1 Receptor Agonists Market Gains Momentum as Weight-Loss Drugs Redefine Diabetes and Heart Care - Says Strategic Market Research

Global GLP-1 Receptor Agonists Market to grow from USD 18.4 billion in 2024 to USD 41.5 billion by 2030 as diabetes treatment, obesity care, cardiovascular risk reduction, oral drug innovation, and payer access reshape metabolic therapeutics SAMBALPUR, India, June 17, 2026 /PRNewswire/ --...